Le Lézard
Classified in: Science and technology
Subjects: Product/Service, Trade Show

Taiwan's Ministry of Economic Affairs Department of Industrial Technology Selects 81 Outstanding Technologies to Strengthen Key Capabilities of Domestic Industries


The 2021 TIE Taiwan Innotech Expo has officially kicked off both online and at Taipei World Trade Center Hall 1 today (October 14th). Taiwan's Ministry of Economic Affairs Department of Industrial Technology (DoIT) selected 68 TDP technologies and 13 TDP-incubated innovative technologies from over a hundred TDPs executed by 17 legal persons for the event. The technologies, which boost industrial upgrading, are displayed in the TIE Discovering Technology Treasures section. Innovative applications of AI and 5G are focus features at the expo, as well as new technologies and industry trends in precision health and low carbon economy.

The TIE Discovering Technology Treasures section presents two major features: crucial technologies for future industrial upgrading and innovative startups that show high potential in the industries. DoIT Director General Chiou Chyou-Huey pointed out that innovation is a key factor in enhancing the global competitiveness of a nation's industry. The 68 selected technologies displayed this year include the AI Assistant of Mammograms, an innovative application of AI that reduces the waiting time for breast cancer test results; and the production of methanol from CO2 with low carbon emission technology introduced by the DoIT in response to EU's carbon border tax policy (that will be implemented in 2023). This technology synthesizes CO2 into low-carbon methanol which can then be mass-produced to supply industrial use and realize circular recycling.

The latest industry trends are presented by the MoEA Dpartment of Industrial Technology (DoIT) at the expo. All visitors and collaboration inquiries are welcome. Come visit the TIE Discovering Technology Treasures expo online between October 14th and 23rd!

Click here to visit the expo! TIE Discovering Technology Treasures section: https://tievirtual.twtm.com.tw/iframe?group=f36efffd-9ee6-4962-aa09-72f6797d2449&lang=en

Discovering Technology Treasures: https://www.tiedtt.tpef888.com/


These press releases may also interest you

at 00:45
At Last, a Worldwide Groundbreaking Solution to Address the Unhoused Crisis
Claudio Bono, Managing Director for two independent Hotels in Silicon Valley, is thrilled to unveil a groundbreaking platform and an idea that will transform the landscape of the urgent unhoused crisis and social issues. Leveraging his extensive...

26 avr 2024
Flash News: OKX Wallet Integrates with Side Protocol
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...

26 avr 2024
Flash News: OKX Wallet Integrates with Bitrubo
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

26 avr 2024
Cognitive Security Market Projected to Reach $134.26 billion by 2030 - Exclusive Report by 360iResearch
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

26 avr 2024
Anti-Mullerian Hormone Test Market Projected to Reach $586.48 million by 2030 - Exclusive Report by 360iResearch
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

More news about Science and technology...


News published on and distributed by: